-transparent.png){kind=logo}
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. 2006
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA. jppowers@amgen.com
Novel non-nucleoside inhibitors of the HCV RNA polymerase (NS5b) with sub-micromolar biochemical potency have been identified which are selective for the inhibition of HCV NS5b over other polymerases. The structures of the complexes formed between several of these inhibitors and HCV NS5b were determined by X-ray crystallography, and the inhibitors were found to bind in an allosteric binding site separate from the active site. Structure-activity relationships and structural studies have identified the mechanism of action for compounds in this series, several of which possess drug-like properties, as unique, reversible, covalent inhibitors of HCV NS5b.
Related Publications
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
March 2012,
Journal of medicinal chemistry,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
January 2015,
Archiv der Pharmazie,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
April 2017,
Journal of medicinal chemistry,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
January 2004,
Bioorganic & medicinal chemistry letters,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
August 2006,
Journal of molecular biology,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
January 2012,
Nucleosides, nucleotides & nucleic acids,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
August 2011,
Antimicrobial agents and chemotherapy,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
January 2016,
Current drug targets,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
October 2003,
Bioorganic & medicinal chemistry letters,
Jay P Powers, and
Derek E Piper, and
Yang Li, and
Veronica Mayorga, and
John Anzola, and
James M Chen, and
Juan C Jaen, and
Gary Lee, and
Jinqian Liu, and
M Greg Peterson, and
George R Tonn, and
Qiuping Ye, and
Nigel P C Walker, and
Zhulun Wang
July 2010,
Bioorganic & medicinal chemistry,
